EUDA Health Holdings Limited Form 6-K Summary
Business Context and Reporting Period
EUDA Health Holdings Limited, a Singapore-based foreign private issuer, filed this Form 6-K for January 2024. The filing reports financing activity under a Convertible Loan Agreement with Gilandi Limited, dated January 16, 2024.
Financing and Key Financial Terms
| Item | Terms |
|---|---|
| Lender | Gilandi Limited, a British Virgin Islands company |
| Principal amount | $500,000 |
| Funding schedule | Two tranches of $250,000 each, due by January 31, 2024 and March 31, 2024 |
| Interest rate | 8% per annum through March 31, 2024 |
| Maturity date | March 31, 2024 |
| Conversion terms | Outstanding balance automatically converts into ordinary shares at $1.00 per share at maturity |
| Funding completed as of filing | A $250,000 convertible note was issued to Gilandi on January 17, 2024 |
The filing does not provide revenue, profit, cash flow, margin, debt-total, liquidity, or other operating financial metrics.
Material Changes Versus Prior Comparable Period
The filing text does not provide comparative-period financial information. The material disclosed event is the commencement of a $500,000 convertible borrowing arrangement, with $250,000 issued as of January 17, 2024 and a second $250,000 tranche scheduled by March 31, 2024.
Outlook, Risks, Contingencies, and Unusual Items
- The loan accrues interest at 8% per annum until the March 31, 2024 maturity date.
- Any outstanding balance at maturity will automatically convert into ordinary shares at $1.00 per share, creating potential equity dilution.
- The filing does not state whether the second tranche was funded, whether the loan was repaid or converted, or whether any default or amendment occurred after the filing date.
- The detailed Convertible Loan Agreement is furnished as Exhibit 10.1 and controls over the abbreviated description in the filing.
Important Facts for Investors to Verify
- Whether the second $250,000 tranche was funded by March 31, 2024.
- The outstanding principal and accrued interest at maturity.
- Whether automatic conversion occurred and the number of ordinary shares issued.
- The Convertible Loan Agreement’s full terms, including events of default, repayment rights, conversion mechanics, and any restrictions or covenants.
- EUDA’s broader liquidity position and ability to fund operations, which are not disclosed in this Form 6-K.